(Q34316692)

1 August 2017

title

Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome (English)

1 reference

1 August 2017

1 reference

Cleare AJ

1

1 reference

1 August 2017

O'Keane V

series ordinal

2

1 reference

1 August 2017

Miell JP

series ordinal

3

1 reference

1 August 2017

publication date

1 July 2004

1 reference

1 August 2017

published in

Psychoneuroendocrinology

1 reference

1 August 2017

volume

29

1 reference

1 August 2017

issue

6

1 reference

1 August 2017

page(s)

724-732

1 reference

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Development of a fatigue scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

The neuroendocrinology of chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Urinary free cortisol in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Plasma leptin in chronic fatigue syndrome and a placebo-controlled study of the effects of low-dose hydrocortisone on leptin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Dehydroepiandrosterone (DHEA) response to i.v. ACTH in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Low dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Low dehydroepiandrosterone sulfate and heart disease in middle-aged men: cross-sectional results from the Massachusetts Male Aging Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Possible role of cortisol and dehydroepiandrosterone in human development and psychopathology

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Core body temperature is normal in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

A pilot study employing Dehydroepiandrosterone (DHEA) in the treatment of chronic fatigue syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

The Work and Social Adjustment Scale: a simple measure of impairment in functioning.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Hormonal responses to exercise in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

The neuroendocrinology of chronic fatigue syndrome and fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

The low dose ACTH test in chronic fatigue syndrome and in health

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Chronic fatigue syndrome. A practical guide to assessment and management

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

The MOS short-form general health survey. Reliability and validity in a patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Somatic Discomforts Among Depressed Women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2803%2900104-5

7 January 2021

10.1016/S0306-4530(03)00104-5

Identifiers

DOI

1 reference

1 August 2017

1 reference